Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 13/20 | 0.41 |
| ▸ | CA1 | P00915 | 10/20 | 0.41 |
| ▸ | CA9 | Q16790 | 9/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | CA4 | P22748 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974416 | 0.93 | CA2 (0.41) | PTGS2CA2CA1CA9CA12 | |
| SCHEMBL8974705 | 0.91 | PTGS2 (0.41) | PTGS2PTGS1 | |
| SCHEMBL8974071 | 0.87 | CA2 (0.41) | PTGS2CA2CA1CA9CA12 | |
| SCHEMBL8973831 | 0.87 | PTGS2 (0.50) | PTGS2CA2CA1CA9CA12 | |
| SCHEMBL8974427 | 0.87 | PTGDR2 (0.39) | PTGS2PTGS1 | |
| SCHEMBL8973885 | 0.86 | KIF11 (0.46) | PTGS2CA2CA1CA9CA12 | |
| SCHEMBL8974144 | 0.84 | KIF11 (0.44) | PTGS2CA2CA1CA9CA12 | |
| SCHEMBL8974147 | 0.83 | PTGS2 (0.45) | PTGS2CA2CA1CA9PTGS1 | |
| SCHEMBL8974639 | 0.83 | CA1 (0.43) | PTGS2CA2CA1CA9CA12 | |
| SCHEMBL8974495 | 0.82 | CA2 (0.44) | PTGS2CA2CA1CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5576339-A | Pyridyl substituted cyclopentadienes for the treatment of inflamation | HUANG HORNG-CHIH (US) | 1996-11-19 | — | — | US | disclosed |
| US-5418254-A | Side effect reduction | G. D. SEARLE & CO. (US) | 1995-05-23 | — | — | US | disclosed |